| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Creotech Instruments S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł209.00 |
| 52 Week High | zł244.00 |
| 52 Week Low | zł164.50 |
| Beta | -0.036 |
| 1 Month Change | 10.58% |
| 3 Month Change | 14.84% |
| 1 Year Change | 14.84% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 183.01% |
Recent News & Updates
Shareholder Returns
| CRI | PL Aerospace & Defense | PL Market | |
|---|---|---|---|
| 7D | 8.9% | 0.5% | 0.9% |
| 1Y | 14.8% | 34.2% | 24.7% |
Return vs Industry: CRI underperformed the Polish Aerospace & Defense industry which returned 34.2% over the past year.
Return vs Market: CRI underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
| CRI volatility | |
|---|---|
| CRI Average Weekly Movement | 4.8% |
| Aerospace & Defense Industry Average Movement | 4.1% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PL Market | 9.5% |
| 10% least volatile stocks in PL Market | 3.3% |
Stable Share Price: CRI has not had significant price volatility in the past 3 months.
Volatility Over Time: CRI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 180 | Grzegorz Brona | www.creotech.pl |
Creotech Instruments S.A. operates in the space and science industry in Poland. The company produces aircrafts, spacecrafts, electronic components, computers and peripheral devices, telecommunications equipment, and related machines. It also manufactures measuring, control, and navigation instruments and devices; produces and distributes electricity; and produces control apparatus.
Creotech Instruments S.A. Fundamentals Summary
| CRI fundamental statistics | |
|---|---|
| Market cap | zł497.28m |
| Earnings (TTM) | -zł11.50m |
| Revenue (TTM) | zł30.95m |
16.1x
P/S Ratio-43.2x
P/E RatioIs CRI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRI income statement (TTM) | |
|---|---|
| Revenue | zł30.95m |
| Cost of Revenue | zł12.48m |
| Gross Profit | zł18.47m |
| Other Expenses | zł29.98m |
| Earnings | -zł11.50m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 29, 2024
| Earnings per share (EPS) | -4.83 |
| Gross Margin | 59.69% |
| Net Profit Margin | -37.17% |
| Debt/Equity Ratio | 8.0% |
How did CRI perform over the long term?
See historical performance and comparison